Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases

Lars Petter Jordheim(Centre de Recherche en Cancérologie de Lyon), David Durantel(Inserm), Fabien Zoulim(Hospices Civils de Lyon), Charles Dumontet(Hospices Civils de Lyon)

Nature Reviews Drug Discovery

May 31, 2013

10.1038/nrd4010

Cited by 1,192

Abstract

Related Papers

Acyclic nucleoside phosphonates: a key class of antiviral drugs

Erik De Clercq, Antonı́n Holý|Nature Reviews Drug Discovery|2005|677

Selective Intracellular Activation of a Novel Prodrug of the Human Immunodeficiency Virus Reverse Transcriptase Inhibitor Tenofovir Leads to Preferential Distribution and Accumulation in Lymphatic Tissue

William A. Lee, Gong-Xin He, Eugene Eisenberg et al.|Antimicrobial Agents and Chemotherapy|2005|339

17th conference on retroviruses and opportunistic infections

修三松下|HIV感染症とAIDSの治療|2010|144

Discovery of New Hexagonal Supramolecular Nanostructures Formed by Squalenoylation of an Anticancer Nucleoside Analogue

Patrick Couvreur, L. Harivardhan Reddy, Stéphanie Mangenot et al.|Small|2008|118

Squalenoyl gemcitabine nanomedicine overcomes the low efficacy of gemcitabine therapy in pancreatic cancer

Soukaina Réjiba, L. Harivardhan Reddy, Christelle Bigand et al.|Nanomedicine Nanotechnology Biology and Medicine|2011|98